Consistent with this, our present data show that inhibition of LRP6 signaling in R6B-Zshigh breast cancer cells induces a reduction in Rad6B promoter activity as evidenced by decrease in Rad6B promoter-mediated ZsGreen and luciferase reporter expressions and Rad6B gene expression. The gene discussed is UBE2B; the disease is breast carcinoma.